 OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to the number of packed red blood cell PRBC units transfused 1 year prior to screening 15 units vs 15-25 units vs 25 units. Patients are randomized to 1 of 2 treatment arms. 